Bavarian Nordic A/S
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BVNKF research report →
Companywww.bavarian-nordic.com
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name. It is also developing MVA-BN (freeze-dried) that has completed Phase III clinical trials for the treatment of smallpox; MVA-BN RSV, which is in Phase III clinical trials for the treatment of respiratory syncytial virus; ABNCoV2 that has completed Phase II clinical trial for the treatment of SARS-CoV-2; and TAEK-VAC, which is in Phase I/II clinical trial for treatment of advanced HER2 and brachyury-expressing cancers.
- CEO
- Paul John Chaplin
- IPO
- 2010
- Employees
- 1,645
- HQ
- Hellerup, DK
Price Chart
Valuation
- Market Cap
- $2.38B
- P/E
- 12.97
- P/S
- 2.57
- P/B
- 1.20
- EV/EBITDA
- 6.53
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 47.40%
- Op Margin
- 25.36%
- Net Margin
- 19.83%
- ROE
- 9.25%
- ROIC
- 8.35%
Growth & Income
- Revenue
- $6.16B · 7.71%
- Net Income
- $1.37B · 38.90%
- EPS
- $17.61 · 39.76%
- Op Income
- $918.69M
- FCF YoY
- 857.65%
Performance & Tape
- 52W High
- $37.60
- 52W Low
- $26.08
- 50D MA
- $30.03
- 200D MA
- $32.33
- Beta
- 0.95
- Avg Volume
- 150
Get TickerSpark's AI analysis on BVNKF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our BVNKF Coverage
We haven't published any research on BVNKF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BVNKF Report →